Peregrine Pharmaceuticals | Lånekapital

Loan Capital Endring Dato
Amgen USD 63.17B 4.13B 2023-12
AstraZeneca USD 22.97B 2.08B 2023-09
Celldex Therapeutics USD 0 0 2022-06
Eli Lilly USD 17.92B 956.9M 2023-09
GlaxoSmithKline GBP 15.99B 440M 2023-09
MacroGenics USD 0 0 2022-06
MannKind USD 479.07M 131.46M 2023-12
Repligen USD 0 0 2022-06
Roche Holding CHF 20.35B 1.05B 2023-06
Xencor USD 14.64M 14.64M 2023-12



Peregrine Pharmaceuticals Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.